NOG anticorps (Middle Region)
Aperçu rapide pour NOG anticorps (Middle Region) (ABIN633158)
Antigène
Voir toutes NOG AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- Noggin antibody was raised against the middle region of NOG
-
Purification
- Affinity purified
-
Immunogène
- Noggin antibody was raised using the middle region of NOG corresponding to a region with amino acids GGHYDPGFMATSPPEDRPGGGGGAAGGAEDLAELDQLLRQRPSGAMPSEI
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
Noggin Blocking Peptide, (ABIN938672), is also available for use as a blocking control in assays to test for specificity of this Noggin antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NOG antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NOG (Noggin (NOG))
-
Autre désignation
- Noggin
-
Sujet
- The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, this protein may have a principal role in creating morphogenic gradients.
-
Poids moléculaire
- 24 kDa (MW of target protein)
-
Pathways
- Stem Cell Maintenance, Tube Formation
Antigène
-